An ensemble approach to predicting the impact of vaccination on rotavirus disease in Niger

Jaewoo Park, Joshua Goldstein, Murali Haran, Matthew Joseph Ferrari

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Recently developed vaccines provide a new way of controlling rotavirus in sub-Saharan Africa. Models for the transmission dynamics of rotavirus are critical both for estimating current burden from imperfect surveillance and for assessing potential effects of vaccine intervention strategies. We examine rotavirus infection in the Maradi area in southern Niger using hospital surveillance data provided by Epicentre collected over two years. Additionally, a cluster survey of households in the region allows us to estimate the proportion of children with diarrhea who consulted at a health structure. Model fit and future projections are necessarily particular to a given model; thus, where there are competing models for the underlying epidemiology an ensemble approach can account for that uncertainty. We compare our results across several variants of Susceptible-Infectious-Recovered (SIR) compartmental models to quantify the impact of modeling assumptions on our estimates. Model-specific parameters are estimated by Bayesian inference using Markov chain Monte Carlo. We then use Bayesian model averaging to generate ensemble estimates of the current dynamics, including estimates of R0, the burden of infection in the region, as well as the impact of vaccination on both the short-term dynamics and the long-term reduction of rotavirus incidence under varying levels of coverage. The ensemble of models predicts that the current burden of severe rotavirus disease is 2.6–3.7% of the population each year and that a 2-dose vaccine schedule achieving 70% coverage could reduce burden by 39–42%.

Original languageEnglish (US)
Pages (from-to)5835-5841
Number of pages7
JournalVaccine
Volume35
Issue number43
DOIs
StatePublished - Oct 13 2017

Fingerprint

Niger
Rotavirus
Vaccination
vaccination
Vaccines
Rotavirus Infections
Markov Chains
Africa South of the Sahara
vaccines
Uncertainty
Diarrhea
Appointments and Schedules
Epidemiology
Incidence
household surveys
Health
monitoring
Infection
Sub-Saharan Africa
Population

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

@article{b9095cdbea254eb29a5dc8fef1e13b7a,
title = "An ensemble approach to predicting the impact of vaccination on rotavirus disease in Niger",
abstract = "Recently developed vaccines provide a new way of controlling rotavirus in sub-Saharan Africa. Models for the transmission dynamics of rotavirus are critical both for estimating current burden from imperfect surveillance and for assessing potential effects of vaccine intervention strategies. We examine rotavirus infection in the Maradi area in southern Niger using hospital surveillance data provided by Epicentre collected over two years. Additionally, a cluster survey of households in the region allows us to estimate the proportion of children with diarrhea who consulted at a health structure. Model fit and future projections are necessarily particular to a given model; thus, where there are competing models for the underlying epidemiology an ensemble approach can account for that uncertainty. We compare our results across several variants of Susceptible-Infectious-Recovered (SIR) compartmental models to quantify the impact of modeling assumptions on our estimates. Model-specific parameters are estimated by Bayesian inference using Markov chain Monte Carlo. We then use Bayesian model averaging to generate ensemble estimates of the current dynamics, including estimates of R0, the burden of infection in the region, as well as the impact of vaccination on both the short-term dynamics and the long-term reduction of rotavirus incidence under varying levels of coverage. The ensemble of models predicts that the current burden of severe rotavirus disease is 2.6–3.7{\%} of the population each year and that a 2-dose vaccine schedule achieving 70{\%} coverage could reduce burden by 39–42{\%}.",
author = "Jaewoo Park and Joshua Goldstein and Murali Haran and Ferrari, {Matthew Joseph}",
year = "2017",
month = "10",
day = "13",
doi = "10.1016/j.vaccine.2017.09.020",
language = "English (US)",
volume = "35",
pages = "5835--5841",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "43",

}

An ensemble approach to predicting the impact of vaccination on rotavirus disease in Niger. / Park, Jaewoo; Goldstein, Joshua; Haran, Murali; Ferrari, Matthew Joseph.

In: Vaccine, Vol. 35, No. 43, 13.10.2017, p. 5835-5841.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An ensemble approach to predicting the impact of vaccination on rotavirus disease in Niger

AU - Park, Jaewoo

AU - Goldstein, Joshua

AU - Haran, Murali

AU - Ferrari, Matthew Joseph

PY - 2017/10/13

Y1 - 2017/10/13

N2 - Recently developed vaccines provide a new way of controlling rotavirus in sub-Saharan Africa. Models for the transmission dynamics of rotavirus are critical both for estimating current burden from imperfect surveillance and for assessing potential effects of vaccine intervention strategies. We examine rotavirus infection in the Maradi area in southern Niger using hospital surveillance data provided by Epicentre collected over two years. Additionally, a cluster survey of households in the region allows us to estimate the proportion of children with diarrhea who consulted at a health structure. Model fit and future projections are necessarily particular to a given model; thus, where there are competing models for the underlying epidemiology an ensemble approach can account for that uncertainty. We compare our results across several variants of Susceptible-Infectious-Recovered (SIR) compartmental models to quantify the impact of modeling assumptions on our estimates. Model-specific parameters are estimated by Bayesian inference using Markov chain Monte Carlo. We then use Bayesian model averaging to generate ensemble estimates of the current dynamics, including estimates of R0, the burden of infection in the region, as well as the impact of vaccination on both the short-term dynamics and the long-term reduction of rotavirus incidence under varying levels of coverage. The ensemble of models predicts that the current burden of severe rotavirus disease is 2.6–3.7% of the population each year and that a 2-dose vaccine schedule achieving 70% coverage could reduce burden by 39–42%.

AB - Recently developed vaccines provide a new way of controlling rotavirus in sub-Saharan Africa. Models for the transmission dynamics of rotavirus are critical both for estimating current burden from imperfect surveillance and for assessing potential effects of vaccine intervention strategies. We examine rotavirus infection in the Maradi area in southern Niger using hospital surveillance data provided by Epicentre collected over two years. Additionally, a cluster survey of households in the region allows us to estimate the proportion of children with diarrhea who consulted at a health structure. Model fit and future projections are necessarily particular to a given model; thus, where there are competing models for the underlying epidemiology an ensemble approach can account for that uncertainty. We compare our results across several variants of Susceptible-Infectious-Recovered (SIR) compartmental models to quantify the impact of modeling assumptions on our estimates. Model-specific parameters are estimated by Bayesian inference using Markov chain Monte Carlo. We then use Bayesian model averaging to generate ensemble estimates of the current dynamics, including estimates of R0, the burden of infection in the region, as well as the impact of vaccination on both the short-term dynamics and the long-term reduction of rotavirus incidence under varying levels of coverage. The ensemble of models predicts that the current burden of severe rotavirus disease is 2.6–3.7% of the population each year and that a 2-dose vaccine schedule achieving 70% coverage could reduce burden by 39–42%.

UR - http://www.scopus.com/inward/record.url?scp=85029580752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029580752&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2017.09.020

DO - 10.1016/j.vaccine.2017.09.020

M3 - Article

C2 - 28941619

AN - SCOPUS:85029580752

VL - 35

SP - 5835

EP - 5841

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 43

ER -